Dear Readers,
Since 2020, more than ever, healthcare has risen to near the top of the political agenda. Inevitably, the topics that define politics attract enhanced antitrust scrutiny, and healthcare is no exception.
Even before the COVID-19 pandemic, antitrust debates have raged in various aspects of the healthcare industry, from the provision of medical services, to patent-related practices in the pharmaceuticals industry.
Practices in healthcare vary considerably throughout the world. The contributions to this Chronicle reflect the diversity of practices in healthcare provision in various jurisdictions, ranging from the concerns raised in more socialized healthcare systems, to concerns relating to vertical integration in more privatized systems.
Despite the diversity of systems throughout the world, practitioners and commentators across jurisdictions have much to learn from each other. The contributions to this Chronicle form a vital contribution to the cross-pollination of information and practices concerning enforcement in healthcare as it continues to develop over the months and years to come.
As always, thank you to our great panel of authors.
Sincerely,
CPI Team
